Tenaya Therapeutics launches with the goal of curing heart disease

(Gladstone Institutes) A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure. The new company combines Gladstone's basic science expertise with the resources and translational know-how of the biotechnology industry.
Source: EurekAlert! - Biology - Category: Biology Source Type: news